Sarah L. DeVos

7.1k total citations · 3 hit papers
24 papers, 3.9k citations indexed

About

Sarah L. DeVos is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sarah L. DeVos has authored 24 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 9 papers in Molecular Biology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sarah L. DeVos's work include Alzheimer's disease research and treatments (16 papers), Neuroscience and Neuropharmacology Research (8 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). Sarah L. DeVos is often cited by papers focused on Alzheimer's disease research and treatments (16 papers), Neuroscience and Neuropharmacology Research (8 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). Sarah L. DeVos collaborates with scholars based in United States, United Kingdom and Switzerland. Sarah L. DeVos's co-authors include Timothy M. Miller, Marc I. Diamond, Bradley T. Hyman, Allyson D. Roe, Brandon B. Holmes, Matthew P. Frosch, C. Frank Bennett, Louise C. Serpell, Hilda Mirbaha and Scarlett J. Barker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Neuron.

In The Last Decade

Sarah L. DeVos

24 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies

2014 720 citations David W. Sanders, Sarah K. Kaufman et al. Neuron profile →
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds

2013 649 citations Brandon B. Holmes, Sarah L. DeVos et al. Proceedings of the National Academy of Sciences profile →
Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy

2017 362 citations Sarah L. DeVos, Rebecca L. Miller et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah L. DeVos United States	22	2.6k	1.6k	1.1k	1.1k	714	24	3.9k
Florence Clavaguera Switzerland	17	2.9k 1.1×	1.6k 1.0×	1.3k 1.2×	1.0k 0.9×	912 1.3×	21	3.8k
Yazi D. Ke Australia	28	2.6k 1.0×	1.6k 1.0×	850 0.7×	1.4k 1.2×	781 1.1×	57	4.2k
Selina Wray United Kingdom	33	2.4k 0.9×	2.1k 1.3×	1.0k 0.9×	1.2k 1.0×	1.0k 1.4×	75	4.7k
Cristian A. Lasagna‐Reeves United States	27	2.8k 1.1×	1.5k 1.0×	1.2k 1.1×	956 0.8×	673 0.9×	52	4.2k
Diana L. Castillo‐Carranza United States	25	2.9k 1.1×	1.4k 0.9×	1.1k 0.9×	1.0k 0.9×	768 1.1×	35	3.6k
Diederik Moechars Belgium	28	1.9k 0.7×	1.3k 0.8×	930 0.8×	1.1k 1.0×	480 0.7×	53	3.8k
Urmi Sengupta United States	33	3.3k 1.3×	1.9k 1.2×	1.2k 1.1×	1.1k 1.0×	990 1.4×	69	4.7k
Celeste M. Karch United States	31	2.5k 0.9×	2.0k 1.2×	1.6k 1.4×	767 0.7×	846 1.2×	75	5.0k
Guilian Xu United States	25	2.4k 0.9×	1.4k 0.9×	922 0.8×	1.0k 0.9×	921 1.3×	49	4.2k

Countries citing papers authored by Sarah L. DeVos

Since Specialization

Citations

This map shows the geographic impact of Sarah L. DeVos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah L. DeVos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah L. DeVos more than expected).

Fields of papers citing papers by Sarah L. DeVos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah L. DeVos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah L. DeVos. The network helps show where Sarah L. DeVos may publish in the future.

Co-authorship network of co-authors of Sarah L. DeVos

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah L. DeVos. A scholar is included among the top collaborators of Sarah L. DeVos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah L. DeVos. Sarah L. DeVos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simon, Matthew, Todd Logan, Sarah L. DeVos, & Gilbert Di Paolo. (2022). Lysosomal functions of progranulin and implications for treatment of frontotemporal dementia. Trends in Cell Biology. 33(4). 324–339. 42 indexed citations

Meisl, Georg, Kieren Allinson, Timothy Rittman, et al.. (2021). In vivo rate-determining steps of tau seed accumulation in Alzheimer’s disease. Science Advances. 7(44). eabh1448–eabh1448. 74 indexed citations

Ramirez, Paulino, Wenyan Sun, Sarah L. DeVos, et al.. (2021). Pathogenic tau accelerates aging-associated activation of transposable elements in the mouse central nervous system. Progress in Neurobiology. 208. 102181–102181. 50 indexed citations

DeVos, Sarah L., Bianca T. Corjuc, Derek H. Oakley, et al.. (2018). Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain. Frontiers in Neuroscience. 12. 267–267. 200 indexed citations

Hopp, Sarah C., Derek H. Oakley, Allyson D. Roe, et al.. (2018). The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer’s disease. Journal of Neuroinflammation. 15(1). 269–269. 209 indexed citations

DeVos, Sarah L., Bianca T. Corjuc, Caitlin Commins, et al.. (2018). Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo. Brain. 141(7). 2194–2212. 79 indexed citations

DeVos, Sarah L. & Bradley T. Hyman. (2017). Tau at the Crossroads between Neurotoxicity and Neuroprotection. Neuron. 94(4). 703–704. 8 indexed citations

Nicholls, Samantha B., Sarah L. DeVos, Caitlin Commins, et al.. (2017). Characterization of TauC3 antibody and demonstration of its potential to block tau propagation. PLoS ONE. 12(5). e0177914–e0177914. 31 indexed citations

Bennett, Rachel E., Sarah L. DeVos, Simon Dujardin, et al.. (2017). Enhanced Tau Aggregation in the Presence of Amyloid β. American Journal Of Pathology. 187(7). 1601–1612. 183 indexed citations

10.

Schoch, Kathleen M., Sarah L. DeVos, Rebecca L. Miller, et al.. (2016). Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse Model. Neuron. 90(5). 941–947. 124 indexed citations

11.

Takeda, Shuko, Susanne Wegmann, Hansang Cho, et al.. (2015). Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer’s disease brain. Nature Communications. 6(1). 8490–8490. 276 indexed citations

12.

Wegmann, Susanne, Eduardo A. Maury, Molly J. Kirk, et al.. (2015). Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity. The EMBO Journal. 34(24). 3028–3041. 93 indexed citations

13.

Sanders, David W., Sarah K. Kaufman, Sarah L. DeVos, et al.. (2014). Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies. Neuron. 82(6). 1271–1288. 720 indexed citations breakdown →

14.

Holmes, Brandon B., Sarah L. DeVos, Najla Kfoury, et al.. (2013). Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proceedings of the National Academy of Sciences. 110(33). E3138–47. 649 indexed citations breakdown →

15.

DeVos, Sarah L., Guojun Chen, Kaoru Yamada, et al.. (2013). Antisense Reduction of Tau in Adult Mice Protects against Seizures. Journal of Neuroscience. 33(31). 12887–12897. 250 indexed citations

16.

DeVos, Sarah L. & Timothy M. Miller. (2013). Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System. Journal of Visualized Experiments. e50326–e50326. 127 indexed citations

17.

DeVos, Sarah L. & Timothy M. Miller. (2013). Antisense Oligonucleotides: Treating Neurodegeneration at the Level of RNA. Neurotherapeutics. 10(3). 486–497. 115 indexed citations

18.

Reinecke, James B., et al.. (2011). Implicating Calpain in Tau-Mediated Toxicity In Vivo. PLoS ONE. 6(8). e23865–e23865. 45 indexed citations

19.

DeVos, Sarah L., C. J. Epstein, Erik A. Carlson, Steve K. Cho, & H P Koeffler. (1995). Transgenic Mice Overexpressing Human Copper/Zinc-Superoxide Dismutase (Cu/Zn Sod) Are Not Resistant to Endotoxic Shock. Biochemical and Biophysical Research Communications. 208(2). 523–531. 17 indexed citations

20.

Sabbioni, E., et al.. (1993). The intensity of vanadium(V)-induced cytotoxicity and morphological transformation in BALB/3T3 cells is dependent on glutathione-mediated bioreduction to vanadium(IV). Carcinogenesis. 14(12). 2565–2568. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact